← Open Payments lookup

HISHAM KORRAA: Open Payments

NPI 1225151202 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,724 in 44 payments from 11 companies in 2025. Trend: 2023 $2,318 · 2024 $2,145 · 2025 $1,724

Food & beverage: $1,724
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$379
Axsome Therapeutics, Inc.4$353
Teva Pharmaceuticals USA, Inc.3$323
ABBVIE INC.6$303
Alkermes, Inc.3$178
Boehringer Ingelheim Pharmaceuticals, Inc.1$49
Bausch Health US, LLC2$48
E.R. Squibb & Sons, L.L.C.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$17
Lundbeck LLC1$16

Products named: CAPLYTA, Auvelity, VRAYLAR, UZEDY, ARISTADA, APLENZIN, COBENFY, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.